Cargando…

Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009

In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Perri, Bianca R., Proops, Douglas, Moonan, Patrick K., Munsiff, Sonal S., Kreiswirth, Barry N., Kurepina, Natalia, Goranson, Christopher, Ahuja, Shama D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166009/
https://www.ncbi.nlm.nih.gov/pubmed/21392426
http://dx.doi.org/10.3201/eid1703.101002
_version_ 1782211104145932288
author Perri, Bianca R.
Proops, Douglas
Moonan, Patrick K.
Munsiff, Sonal S.
Kreiswirth, Barry N.
Kurepina, Natalia
Goranson, Christopher
Ahuja, Shama D.
author_facet Perri, Bianca R.
Proops, Douglas
Moonan, Patrick K.
Munsiff, Sonal S.
Kreiswirth, Barry N.
Kurepina, Natalia
Goranson, Christopher
Ahuja, Shama D.
author_sort Perri, Bianca R.
collection PubMed
description In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-four geographically clustered cases were identified during 2003–2009. Initially, the M. tuberculosis strain was drug susceptible. However, in 2006, isoniazid resistance emerged, resulting in isoniazid-resistant M. tuberculosis among 17 (31%) patients. Compared with patients with drug-susceptible M. tuberculosis, a greater proportion of patients with isoniazid-resistant M. tuberculosis were US born and had a history of illegal drug use. No patients named one another as contacts. We used patient photographs to identify links between patients. Three links were associated with drug use among patients infected with isoniazid-resistant M. tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved.
format Online
Article
Text
id pubmed-3166009
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-31660092011-11-15 Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 Perri, Bianca R. Proops, Douglas Moonan, Patrick K. Munsiff, Sonal S. Kreiswirth, Barry N. Kurepina, Natalia Goranson, Christopher Ahuja, Shama D. Emerg Infect Dis Research In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-four geographically clustered cases were identified during 2003–2009. Initially, the M. tuberculosis strain was drug susceptible. However, in 2006, isoniazid resistance emerged, resulting in isoniazid-resistant M. tuberculosis among 17 (31%) patients. Compared with patients with drug-susceptible M. tuberculosis, a greater proportion of patients with isoniazid-resistant M. tuberculosis were US born and had a history of illegal drug use. No patients named one another as contacts. We used patient photographs to identify links between patients. Three links were associated with drug use among patients infected with isoniazid-resistant M. tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved. Centers for Disease Control and Prevention 2011-03 /pmc/articles/PMC3166009/ /pubmed/21392426 http://dx.doi.org/10.3201/eid1703.101002 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Perri, Bianca R.
Proops, Douglas
Moonan, Patrick K.
Munsiff, Sonal S.
Kreiswirth, Barry N.
Kurepina, Natalia
Goranson, Christopher
Ahuja, Shama D.
Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title_full Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title_fullStr Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title_full_unstemmed Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title_short Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
title_sort mycobacterium tuberculosis cluster with developing drug resistance, new york, new york, usa, 2003–2009
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166009/
https://www.ncbi.nlm.nih.gov/pubmed/21392426
http://dx.doi.org/10.3201/eid1703.101002
work_keys_str_mv AT perribiancar mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT proopsdouglas mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT moonanpatrickk mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT munsiffsonals mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT kreiswirthbarryn mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT kurepinanatalia mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT goransonchristopher mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009
AT ahujashamad mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009